Whole-flow synthesis process of morpholino nucleoside monomer based on unprotected ring expansion strategy
Direct synthesis of morpholino nucleoside monomers through the unprotected ring expansion strategy, solving the high cost and environmental burden caused by the hydroxyl protection and deprotection steps in the prior art, and achieving high-efficiency and low-cost morpholino nucleoside monomers synthesis, suitable for industrial production.
Patent Information
- Application Number
- CN202410935827.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2023-12-08
- Filing Date
- 2024-07-12
- Publication Date
- 2024-11-22
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
In the existing morpholino nucleoside monomer synthesis process, the ring expansion reaction of the five-membered sugar ring requires hydroxyl protection and deprotection steps, resulting in high production costs, large environmental burden, and the problem of more than three wastes, making it difficult to achieve large-scale production. .
Adopting the unprotected ring expansion strategy, eliminating the protection and deprotection steps of the hydroxyl group at No. 5 position, the unsubstituted morpholino nucleoside monomer is directly synthesized through oxidation, amination and hydrogenation reduction reactions, simplifying the process flow and avoiding column chromatography Purification, simple operation, suitable for industrial production.
It significantly improves synthesis efficiency and yield, reduces reaction costs, reduces waste, simplifies the post-treatment process, is suitable for large-scale production, and provides efficient technical support for the simple preparation of PMO.
Smart Images

Figure CN118994133A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of morpholino nucleoside monomer synthesis, and in particular to a full-process synthesis process of morpholino nucleoside monomers based on an unprotected ring expansion strategy. Background Art
[0002] Phosphorodiamidate morpholino oligonucleotide (PMO) is an artificially modified antisense oligonucleoside chain with morpholino nucleosides as monomers and usually connected by phosphoramide structures. It can highly selectively hybridize with DNA or RNA chains based on the principle of base complementary pairing, and regulate protein biosynthesis by blocking specific mRNA sequences. It has been widely used in the fields of gene function regulation.
[0003] The general synthesis route of PMO is shown in formula (A):
[0004]
[0005] The main steps include:
[0006] ①Synthesis of morpholino nucleoside monomers and protection of key groups (compound 1→2);
[0007] ② The phosphamide structure and morpholino nucleoside are dehydrated and condensed to construct phosphamide morpholino nucleoside (compound 2→3);
[0008] ③Solid phase synthesis of phosphoamide morpholino oligonucleotide chain and removal of protecting group (compound 3→4).
[0009] Therefore, optimizing and improving the synthesis process of 7'-hydroxy-N-trityl-morpholino nucleoside monomer (Compound 2) has important application value for the development of PMO structure antisense oligonucleotide drugs.
[0010] In the synthesis process of 7'-hydroxy-N-trityl-morpholino nucleoside monomer, the key step is the ring expansion reaction of the five-membered sugar ring to construct the six-membered ring morpholino nucleoside.
[0011] The ring expansion reaction involves oxidation, amination and reduction steps. The US patent application publication number US5185444A reports a ring expansion strategy in the presence of sodium periodate, ammonia and sodium cyanoborohydride, in which the nucleoside position 5 needs to be protected with a TBS group in advance. Document 1 (Zhang, N.; Tan, C.; Cai, P.; Jiang, Y.; Zhang, P.; Zhao, Y. Tetrahedron Letters 2008, 49, 3570-3573.) reports that the nucleoside protected by the commonly used DNA protecting group, i.e., the DMTr group, can also achieve the ring expansion reaction of the nucleoside molecule from a five-membered ring to a six-membered ring in the presence of sodium periodate, ammonium borate and sodium cyanoborohydride. Reference 2 (Pattanayak, S.; Paul, S.; Nandi, B.; Sinha, S. Nucleosides Nuclectides Nucleic Acids, 2012, 31, 763-782.) further optimized the replacement of the hydroxyl protecting group under the same reaction conditions, using tert-butyldiphenylsilyl (TBDPS) as the hydroxyl protecting group, which can also successfully achieve the ring expansion reaction and improve the reaction yield.
[0012] However, the protection and deprotection of hydroxyl groups inevitably lead to higher production costs and impose a greater burden on the environment. Summary of the invention
[0013] In view of the above technical problems and the shortcomings in the art, the present invention provides a full-process synthesis process of morpholino nucleoside monomers based on an unprotected ring expansion strategy, which omits the steps of protecting and deprotecting the hydroxyl group at the fifth position of the five-membered sugar ring, has small waste, low cost, convenient post-treatment, and is easy to scale production; the monomer synthesis process is optimized, the use of column chromatography purification method is avoided, the operation is simple, and industrial scale-up is easy, providing technical support for the efficient synthesis of morpholino nucleoside monomers for the simple preparation of PMO.
[0014] A full-process synthesis process of a morpholino nucleoside monomer based on an unprotected ring expansion strategy comprises: dissolving a ribonucleoside in a first solvent, adding an oxidant for sufficient reaction, directly adding an amine source, filtering to obtain a clear liquid after sufficient reaction, adding a hydrogenation reducing agent, concentrating to remove the first solvent after sufficient reaction to obtain an oily substance, adding a good solvent for dilution, then dropping a poor solvent to precipitate a solid, separating the solid from the liquid, beating the solid with a poor solvent, then separating the solid from the liquid, washing the solid, and drying to obtain an unsubstituted morpholino nucleoside monomer;
[0015] The ribonucleoside has a structure as shown in the following formula (I):
[0016]
[0017] The unsubstituted morpholino nucleoside monomer has a structure shown in the following formula (II):
[0018]
[0019] In formula (I) and formula (II), B represents a base, which is guanine, cytosine, adenine, uracil or thymine, and the specific structures are shown below:
[0020]
[0021] In one embodiment, in the full-process synthesis process of morpholino nucleoside monomers based on the unprotected ring expansion strategy, the molar ratio of ribonucleoside, oxidant, amine source and hydrogenation reducing agent can be 1:1.05-1.15:1.25-1.35:1.45-1.55.
[0022] In the full-process synthesis process of morpholino nucleoside monomers based on an unprotected ring-expansion strategy, the oxidant may include sodium periodate.
[0023] In the full-process synthesis process of morpholino nucleoside monomers based on an unprotected ring expansion strategy, the amine source may include (NH4)2B4O7·4H2O.
[0024] In the full-process synthesis process of morpholino nucleoside monomers based on an unprotected ring-expansion strategy, the hydrogenation reducing agent may include NaCNBH3.
[0025] In the full-process synthesis process of morpholino nucleoside monomers based on an unprotected ring-expansion strategy, the first solvent may include at least one of water, methanol, and ethanol.
[0026] In one embodiment, in the full-process synthesis process of morpholino nucleoside monomer based on the unprotected ring expansion strategy, the ratio of the first solvent to the ribonucleoside is no more than 250 mL:1 mmol.
[0027] In one embodiment, in the full-process synthesis process of morpholino nucleoside monomers based on an unprotected ring-expansion strategy, the oxidant can be added in the form of an aqueous oxidant solution.
[0028] In one embodiment, in the full-process synthesis process of morpholino nucleoside monomers based on an unprotected ring-expansion strategy, the concentration of the oxidant in the oxidant aqueous solution is not less than 0.9 mmol / mL.
[0029] In one embodiment, in the full-process synthesis process of morpholino nucleoside monomer based on the unprotected ring-expansion strategy, the specific operation of filtering to obtain a clear liquid may include: filtering with diatomaceous earth, washing the filter cake with the first solvent, collecting the filtrate and the washing liquid, adding anhydrous sodium sulfate to dry, and filtering to obtain a clear liquid.
[0030] In one embodiment, in the full-process synthesis process of morpholino nucleoside monomers based on an unprotected ring-expansion strategy, the ratio of the first solvent used for washing the filter cake to the ribonucleoside is no more than 5 mL:1 mmol.
[0031] In one embodiment, in the full-process synthesis process of morpholino nucleoside monomer based on the unprotected ring expansion strategy, an acidic polar solvent may also be added when the hydrogenation reducing agent is added.
[0032] In the full-process synthesis process of morpholino nucleoside monomers based on an unprotected ring-expansion strategy, the acidic polar solvent may include acetic acid.
[0033] In one embodiment, in the full-process synthesis process of morpholino nucleoside monomers based on an unprotected ring-expansion strategy, the molar ratio of the acidic polar solvent to the ribonucleoside is no more than 1.8:1.
[0034] In one embodiment, in the full-process synthesis process of morpholino nucleoside monomer based on the unprotected ring expansion strategy, after sufficient reaction and before concentrating and removing the first solvent, a base may be added to neutralize the acidic polar solvent.
[0035] In the full-process synthesis process of morpholino nucleoside monomers based on an unprotected ring expansion strategy, the base may include triethylamine.
[0036] In the full-process synthesis process of morpholino nucleoside monomers based on an unprotected ring-expansion strategy, the good solvent may include at least one of methanol and ethanol.
[0037] In one embodiment, in the full-process synthesis process of morpholino nucleoside monomers based on an unprotected ring-expansion strategy, the ratio of the good solvent to the ribonucleoside is no more than 5 mL:1 mmol.
[0038] In the full-process synthesis process of morpholino nucleoside monomer based on the unprotected ring expansion strategy, the poor solvent may include at least one of acetonitrile and methyl tert-butyl ether (MTBE).
[0039] In one embodiment, in the full-process synthesis process of morpholino nucleoside monomer based on the unprotected ring expansion strategy, the ratio of the poor solvent added dropwise for precipitating the solid to the ribonucleoside is no more than 50 mL:1 mmol.
[0040] In one embodiment, in the full-process synthesis process of morpholino nucleoside monomers based on the unprotected ring-expansion strategy, the ratio of the poor solvent used for slurrying to the ribonucleoside is no more than 10 mL: 1 mol.
[0041] In one embodiment, in the full-process synthesis process of morpholino nucleoside monomers based on an unprotected ring-expansion strategy, the detergent used for washing the solid is the poor solvent.
[0042] In one embodiment, in the full-process synthesis process of morpholino nucleoside monomers based on an unprotected ring-expansion strategy, the ratio of the detergent to the ribonucleoside is no more than 5 mL:1 mol.
[0043] The full-process synthesis process of the morpholino nucleoside monomer based on the unprotected ring expansion strategy may also include:
[0044] N-alkylation reaction of the morpholine ring of unsubstituted morpholino nucleoside monomers to synthesize N-substituted morpholino nucleoside monomers;
[0045] And the N'-acylation reaction on the base of the N-substituted morpholino nucleoside monomer can be selectively carried out to synthesize morpholino N'-substituted nucleoside monomer derivatives.
[0046] The full-process synthesis process of morpholino nucleoside monomers based on the unprotected ring expansion strategy of the present invention is a simple synthesis process of three-step serial reactions such as oxidative ring-opening reaction of sugar ring, amination cyclization reaction, and hydrogenation reduction reaction, which solves the problems of excessive waste and high cost caused by the additional steps such as hydroxyl protection and deprotection in the existing synthesis process of morpholino nucleoside monomers. In addition, the morpholino nucleoside monomers prepared by the unprotected sugar ring expansion process of the present invention can be derived through N-alkylation reaction on the morpholine ring or N'-acylation reaction on the base to prepare a series of substituted morpholino nucleoside monomers.
[0047] The route for synthesizing the N-substituted morpholino nucleoside monomer by N-alkylation reaction on the morpholine ring of the unsubstituted morpholino nucleoside monomer can be represented as follows:
[0048]
[0049] Among them, R 1 The group can be trityl, C1~C 10 Saturated aliphatic hydrocarbon, C2~C 10 Unsaturated aliphatic hydrocarbon, C2~C 10 Alkoxy, C6~C 10 Aryl, -CH2-(OCH2-CH2) n OP1, -CH2-(OCH2-CH2) n NHP1, -CH2-(OCH2-CH2) n SP1 or -CH2-(SCH2-CH2) n SP1, where n is 0 to 10, P1 is H, C1 to C 10 Saturated aliphatic hydrocarbon, C2~C 10 Unsaturated aliphatic hydrocarbon, C2~C 10 Alkoxy or C6~C 10 Aryl.
[0050] The specific operation of synthesizing the N-substituted morpholino nucleoside monomer by N-alkylation reaction on the morpholine ring of the unsubstituted morpholino nucleoside monomer may include:
[0051] The unsubstituted morpholino nucleoside monomer was dissolved in the second solvent, and the pH was adjusted to 8-9 by adding alkali under ice-water bath cooling. 1 After the alkylating agent of the group is added dropwise, the reaction is completed at room temperature, and the reaction is quenched with water to precipitate a solid. The solid is separated from the liquid and washed, and then slurried with a third solvent and dried to obtain an N-substituted morpholino nucleoside monomer.
[0052] The second solvent may include DMF (N,N-dimethylformamide).
[0053] The base may include at least one of potassium tert-butoxide and triethylamine.
[0054] The alkylating agent is dissolved in the second solvent and then added dropwise.
[0055] The third solvent may include toluene.
[0056] The route for synthesizing the morpholino N'-substituted nucleoside monomer derivative by N'-acylation reaction on the base of the N-substituted morpholino nucleoside monomer can be represented as follows:
[0057]
[0058] Among them, R 2 The group can be C1~C 10 Saturated aliphatic hydrocarbon, C2~C 10 Unsaturated aliphatic hydrocarbon, C2~C 10 Alkoxy or C6~C 10 Aryl.
[0059] The specific operation of synthesizing the morpholino N'-substituted nucleoside monomer derivative by the N'-acylation reaction on the base of the N-substituted morpholino nucleoside monomer may include:
[0060] The fourth solvent is used to dissolve the N-substituted morpholino nucleoside monomer, and the solvent used to introduce R 2 The acyl chloride reagent of the group is fully reacted under alkaline environment, quenched with water, the organic phase is extracted and combined, water is removed, concentrated, and crystallized with an anti-solvent. The obtained solid is slurried with a fifth solvent, solid-liquid separation is performed, and drying is performed to obtain a morpholino N'-substituted nucleoside monomer derivative.
[0061] The fourth solvent may include THF (tetrahydrofuran).
[0062] The alkaline environment can be provided by at least one of triethylamine and N,N-diisopropylethylamine.
[0063] The extractant used in the extraction may include EA (ethyl acetate).
[0064] The water removal was performed using anhydrous sodium sulfate.
[0065] The fifth solvent may include at least one of petroleum ether, acetonitrile, and n-hexane.
[0066] Compared with the prior art, the present invention has the following beneficial effects:
[0067] 1. The present invention adopts an unprotected ribonucleoside sugar ring expansion strategy to synthesize morpholino nucleoside monomers. Compared with the traditional method of silicon-based hydroxyl protection strategy, the two-step reaction of adding and removing protecting groups is omitted, which significantly improves the synthesis efficiency. The yield is not less than 30%, which is significantly higher than the yield of less than 20% in the prior art.
[0068] 2. The technical solution provided by the present invention is simple to operate, raw materials and reagents are easily available, reaction cost is low, reaction conditions are mild, substrates are widely applicable, and functional group compatibility is good.
[0069] 3. The present invention avoids the use of column chromatography purification method, has small waste, low cost, convenient post-treatment, simple operation, and easy industrial scale-up, providing technical support for the efficient synthesis of morpholino nucleoside monomers for the simple preparation of PMO. BRIEF DESCRIPTION OF THE DRAWINGS
[0070] Figure 1 For the morpholino cytosine nucleoside monomer 2-C 1 H NMR spectrum;
[0071] Figure 2 N-trityl-morpholinocytidine nucleoside monomer 3-C 1 H NMR spectrum;
[0072] Figure 3 N-trityl-morpholino-N'-benzoyl-cytosine nucleoside monomer 4-C 1 HNMR spectrum. DETAILED DESCRIPTION
[0073] The present invention will be further described below in conjunction with the accompanying drawings and specific embodiments. It should be understood that these embodiments are only used to illustrate the present invention and are not used to limit the scope of the present invention.
[0074] Example 1
[0075] The synthesis of morpholino cytosine nucleoside monomer (2-C) is as follows:
[0076]
[0077] Cytidine substrate 1-C (5.00 g, 20.56 mmol, 1.0 eq.) was dissolved in 250 mL EtOH at room temperature, and 25 mL of NaIO4 (4.83 g, 22.61 mmol, 1.1 eq.) dissolved in water was added and stirred for 15 minutes. After TLC monitoring the complete conversion of the raw material (developing solvent: MeOH:DCM = 1:2), (NH4)2B4O7·4H2O (3.55 g, 26.72 mmol, 1.30 eq.) was added and stirred for 1.5 hours. After TLC monitoring the complete conversion of the intermediate (developing solvent: MeOH:DCM = 1:2), it was filtered with diatomaceous earth, the filter cake was washed with 5 mL of anhydrous ethanol, anhydrous Na2SO4 was added to dry, and a clear solution was obtained by filtration. NaCNBH3 (1.94 g, 30.84 mmol, 1.5 eq.) and AcOH (2.22 g, 37.01 mmol, 1.8 eq.) were added to the clear solution. After stirring for 1.5 hours, the reaction was completed as monitored by TLC (developing solvent: MeOH:DCM = 1:2). TEA (3.7 g, 37.01 mmol, 1.8 eq.) was added to neutralize the acetic acid. The ethanol was removed by concentration to obtain an oily substance. 5 mL of MeOH was added to dilute it. 50 mL of acetonitrile was slowly added dropwise until a large amount of solid precipitated. The oily substance was filtered, and 10 mL of acetonitrile was used for secondary filtration. The filter cake was washed with 5 mL of acetonitrile + MTBE. After being drained, it was dried in a vacuum oven at 35 ° C to obtain the target product 2-C as a light yellow solid with a yield of 34%. 1 HNMR (500MHz, DMSO-d6) δ7.64(d,J=8.1Hz,1H),7.12(d,J=47.0Hz,2H),5.68(s,2H),4.81(s,1H),4.09(dt,J1=18.9,J2=5. 8Hz,1H),3.99(dd,J1=6.5,J2=3.0Hz,1H),3.81(p,J=4.3Hz,1H),3.63-3.57(m,1H),3.53-3.22(m,4H).LC-MS(m / z):Calcd for[M+H] + :267.1066.Found:227.1120.Hydrogen spectrum Figure 1 shown.
[0078] Example 2
[0079] The synthesis of morpholino adenine nucleoside monomer (2-A) is as follows:
[0080]
[0081] In the synthesis of morpholino adenine nucleoside monomer 2-A, in addition to the raw materials, Example 2 is different from Example 1 in that the reaction solvent is a mixture of EtOH and H2O in a volume ratio of 4:1, and other conditions are the same as Example 1, with a yield of 30%.
[0082] Example 3
[0083] The synthesis of morpholinoguanine nucleoside monomer (2-G) is as follows:
[0084]
[0085] In the synthesis of morpholinoguanosine nucleoside monomer 2-G, in addition to the raw materials, Example 3 is different from Example 1 in that the reaction solvent is provided by MeOH, and the other conditions are the same as Example 1, with a yield of 36%.
[0086] Example 4
[0087] The synthesis of morpholino thymidine nucleoside monomer (2-T) is as follows:
[0088]
[0089] In the synthesis of morpholinothymidine monomer 2-T, in addition to the raw materials, Example 4 is different from Example 1 in that the reaction solvent is provided by MeOH, and the other conditions are the same as Example 1, with a yield of 41%.
[0090] Example 5
[0091] The synthesis of morpholino uridine nucleoside monomer (2-U) is as follows:
[0092]
[0093] In the synthesis of morpholino uridine nucleoside monomer 2-U, in addition to the raw materials, Example 5 is different from Example 1 in that the reaction solvent is provided by MeOH, and the other conditions are the same as Example 1, with a yield of 48%.
[0094] Example 6
[0095] The synthesis of N-trityl-morpholino cytosine nucleoside monomer (3-C) is as follows:
[0096]
[0097] At room temperature, 50 mL of DMF-dissolved morpholino cytosine nucleoside monomer substrate solution (1.57 g, 6.94 mmol, 1.0 eq.) was cooled to 0°C with an ice-water bath, TEA (1.05 g, 10.42 mmol, 1.5 eq.) was added to adjust the pH to 8-9, and stirred for 10 minutes. After the pH stabilized at 8-9, 4 mL of DMF-dissolved triphenylmethane chloroform TrCl (2.51 g, 9.02 mmol, 1.3 eq.) was slowly added dropwise. After the addition was completed in 1 hour, the reaction was allowed to proceed at room temperature for 4 hours. TLC monitored the reaction to be complete (developing solvent: MeOH: DCM = 1:10). The reaction solution was slowly stirred and poured into 10 mL of water for quenching. A large amount of solid precipitation was observed. The precipitate was filtered and separated, and the filter cake was washed with 2 mL of water to obtain a crude product. The crude product was slurried with 6 mL of toluene and dried in a vacuum oven at 40°C to obtain a white solid target product 3-C (2.31 g, 4.93 mmol), with a yield of 71%. 1 H NMR(500MHz,DMSO-d6)δ7.57-7.11(m,17H),6.00(dd,J1=9.3,J2=2.3Hz,1H),5.60(d,J=7.5Hz,1 H),4.74(t,J=5.8Hz,1H),4.11(dp,J1=7.5,J2=3.6,J3=2.2Hz,1H),3.40(dd,J1=11.9,J2=5.9Hz, 1H),3.33(s,1H),3.30(dt,J1=11.3,J2=5.6Hz,1H),3.14(dt,J1=11.1,J2=2.5Hz,1H),3.06(dt, J1=12.1,J2=2.2Hz,1H),1.32-1.26(m,1H),1.16(dd,J1=11.0,J2=9.3Hz,1H).LC-MS(m / z):Calcd for[M+Na] + :491.2054.Found:491.2076.Hydrogen spectrum Figure 2 shown.
[0098] Example 7
[0099] The synthesis of N-trityl-morpholino adenine nucleoside monomer (3-A) is as follows:
[0100]
[0101] In the synthesis of N-trityl-morpholino adenine nucleoside monomer 3-A, in addition to the raw materials, Example 7 is different from Example 6 in that the alkaline conditions are changed from t BuOK was provided, and other conditions were the same as in Example 6, with a yield of 75%.
[0102] Example 8
[0103] The synthesis of N-trityl-morpholinoguanine nucleoside monomer (3-G) is as follows:
[0104]
[0105] In the synthesis of N-trityl-morpholinoguanine nucleoside monomer 3-G, apart from the raw materials, Example 8 is different from Example 6 in that the reaction condition is 3 hours, and the other conditions are the same as Example 6, with a yield of 69%.
[0106] Example 9
[0107] The synthesis of N-trityl-morpholinothymidine nucleoside monomer (3-T) is as follows:
[0108]
[0109] In the synthesis of N-trityl-morpholinothymidine monomer 3-T, except for the raw materials, Example 9 is different from Example 6 in that the reaction condition is 2 hours, and the other conditions are the same as Example 6, with a yield of 79%.
[0110] Example 10
[0111] The synthesis of N-trityl-morpholino uridine nucleoside monomer (3-U) is as follows:
[0112]
[0113] In the synthesis of N-trityl-morpholino uridine nucleoside monomer 3-U, except for the raw materials, Example 10 is different from Example 6 in that the reaction condition is 3 hours, and the other conditions are the same as Example 6, with a yield of 83%.
[0114] Embodiment 11
[0115] The synthesis of N-trityl-morpholino-N'-benzoyl-cytosine nucleoside monomer (4-C) is as follows:
[0116]
[0117] Dissolve N-trityl-morpholinocytosine nucleoside monomer 3-C (1.00 g, 2.13 mmol, 1.0 eq.) in 15 mL THF, cool to 0°C in an ice bath, and then add benzoyl chloride BzCl (0.30 g, 2.13 mmol, 1.0 eq.) dropwise. After the addition is complete, remove the ice bath and return to room temperature. TEA (0.22 g, 2.13 mmol, 1.0 eq.) was slowly added dropwise. After 1 hour of addition, the mixture was stirred until the reaction was complete (developing solvent: EA:PE = 10:1 to monitor whether the disubstitution side reaction occurred; developing solvent: DCM:MeOH = 10:1 to monitor whether the raw material reacted completely). 3 mL of water was added to quench the reaction. The organic phase was extracted with 10 mL of EA. After sufficient stirring to dissolve, the mixture was separated. Anhydrous Na2SO4 was added to the organic phase. The mixture was stirred for 30 min to remove water. The mixture was filtered and concentrated. After dilution with 1 mL of dichloromethane DCM, 2 mL of n-hexane was added to precipitate the solid. The mixture was stirred for 10 min, filtered, and 3 mL of mixed solvent (volume ratio (acetonitrile: n-hexane) = 1:2) was added. The mixture was slurried for 1 h, filtered, and dried in a vacuum oven at 40 °C to obtain the target product 4-C (0.91 g, 75%). 1 H NMR(500MHz,DMSO-d6)δ11.22(s,1H),8.03-7.91(m,3H),7.62(t,J=7.4Hz,1H),7.53-7 .18(m,17H),6.11(dd,J1=9.2,J2=2.3Hz,1H),4.76(t,J=5.9Hz,1H),4.21(dtd,J1=10.6 ,J2=5.2,J3=2.1Hz,1H),3.47-3.41(m,1H),3.38(q,J=5.7Hz,1H),3.31(s,2H),3.10(dt ,J1=12.1,J2=2.5Hz,1H),1.39(t,J=11.1Hz,1H),1.25-1.23(m,1H).LC-MS(m / z):Calcd for[MH] + :572.2424.Found:571.2348.Hydrogen spectrum Figure 3 shown.
[0118] Example 12
[0119] The synthesis of N-trityl-morpholino-N'-benzoyl-adenine nucleoside monomer (4-A) is as follows:
[0120]
[0121] The synthesis of N-trityl-morpholino-N'-benzoyl-adenine nucleoside monomer 4-A was carried out under the same conditions as in Example 11 except for the different starting materials, with a yield of 70%.
[0122] Embodiment 13
[0123] The synthesis of N-trityl-morpholino-N'-isobutyryl-guanine nucleoside monomer (4-G) is as follows:
[0124]
[0125] In the synthesis of N-trityl-morpholino-N'-isobutyryl-guanine nucleoside monomer 4-G, in addition to the different raw materials, Example 13 is different from Example 11 in that the acylating agent is isobutyryl chloride, the alkaline condition is provided by N,N-diisopropylethylamine (DIEA), and the other conditions are the same as Example 11, with a yield of 71%.
[0126] In addition, it should be understood that after reading the above description of the present invention, those skilled in the art may make various changes or modifications to the present invention, and these equivalent forms also fall within the scope defined by the claims attached to this application.
Claims
1. A full-process synthesis process of morpholino nucleoside monomers based on an unprotected ring expansion strategy, characterized in that: include: The ribonucleoside is dissolved in a first solvent, an oxidant is added to react sufficiently, an amine source is directly added, a clear liquid is filtered after sufficient reaction, a hydrogenation reducing agent is added, the first solvent is concentrated to remove the first solvent after sufficient reaction, an oil is obtained, a good solvent is added to dilute, a poor solvent is added dropwise to precipitate a solid, a poor solvent is used for slurrying after solid-liquid separation, and then solid-liquid separation is performed, the solid is washed, and dried to obtain an unsubstituted morpholino nucleoside monomer; The ribonucleoside has a structure as shown in the following formula (I): The unsubstituted morpholino nucleoside monomer has a structure shown in the following formula (II): In formula (I) and formula (II), B represents a base, which is guanine, cytosine, adenine, uracil or thymine, and the specific structures are shown below:
2. The full-process synthesis process of morpholino nucleoside monomers based on an unprotected ring expansion strategy according to claim 1, characterized in that: The molar ratio of ribonucleoside, oxidant, amine source and hydrogenation reducing agent is 1:1.05-1.15:1.25-1.35:1.45-1.55; The oxidizing agent includes sodium periodate; The amine source includes (NH4)2B4O7·4H2O; The hydrogenation reducing agent includes NaCNBH3.
3. The full-process synthesis process of morpholino nucleoside monomers based on an unprotected ring expansion strategy according to claim 1, characterized in that: The first solvent includes at least one of water, methanol and ethanol; The usage ratio of the first solvent to the ribonucleoside is no more than 250 mL:1 mmol.
4. The full-process synthesis process of morpholino nucleoside monomers based on an unprotected ring expansion strategy according to claim 1, characterized in that: The oxidant is added in the form of an oxidant aqueous solution; The concentration of the oxidant in the oxidant aqueous solution is not less than 0.9 mmol / mL.
5. The full-process synthesis process of morpholino nucleoside monomers based on an unprotected ring expansion strategy according to claim 1, characterized in that: The specific operation of filtering to obtain a clear liquid includes: filtering with diatomaceous earth, washing the filter cake with the first solvent, collecting the filtrate and the washing liquid, adding anhydrous sodium sulfate to dry, and filtering to obtain a clear liquid; The ratio of the first solvent used for washing the filter cake to the ribonucleoside is no more than 5 mL:1 mmol.
6. The full-process synthesis process of morpholino nucleoside monomers based on an unprotected ring expansion strategy according to claim 1, characterized in that: When the hydrogenation reducing agent is added, an acidic polar solvent is also added; The acidic polar solvent includes acetic acid; The molar ratio of the acidic polar solvent to the ribonucleoside is no more than 1.8:1; After sufficient reaction and before concentrating and removing the first solvent, adding a base to neutralize the acidic polar solvent; The base includes triethylamine.
7. The full-process synthesis process of morpholino nucleoside monomers based on an unprotected ring expansion strategy according to claim 1, characterized in that: The good solvent includes at least one of methanol and ethanol; The usage ratio of the good solvent to the ribonucleoside is no more than 5 mL:1 mmol.
8. The full-process synthesis process of morpholino nucleoside monomers based on an unprotected ring expansion strategy according to claim 1, characterized in that: The poor solvent includes at least one of acetonitrile and methyl tert-butyl ether; The ratio of the poor solvent added dropwise to the ribonucleoside for precipitating the solid is no more than 50 mL:1 mmol; The ratio of the poor solvent used for pulping to the ribonucleoside is no more than 10mL:1mol.
9. The full-process synthesis process of morpholino nucleoside monomers based on an unprotected ring expansion strategy according to claim 1 or 8, characterized in that: The detergent used for washing the solid is the poor solvent; The usage ratio of the detergent to the ribonucleoside is no more than 5 mL:1 mol.
10. The full-process synthesis process of morpholino nucleoside monomers based on an unprotected ring expansion strategy according to any one of claims 1 to 9, characterized in that: The full-process synthesis process of the morpholino nucleoside monomer based on the unprotected ring expansion strategy also includes: N-alkylation reaction of the morpholine ring of unsubstituted morpholino nucleoside monomers to synthesize N-substituted morpholino nucleoside monomers; And the N'-acylation reaction on the base of the N-substituted morpholino nucleoside monomer can be selectively carried out to synthesize morpholino N'-substituted nucleoside monomer derivatives.
Citation Information
Patent Citations
Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages
US5185444A
Oligonucleotides containing nucleotide analogs
CN114728999A
Synthesis of fmoc-protected morpholino monomers and oligomers
US20230097585A1
Cited By
Synthetic method of medical intermediate PMO-G (N2-iBu)
CN120058705A
